In an attempt to decipher how loss of Egr1 accelerated the initiation and progression of CML, we investigated how its loss impacted on the survival and proliferation of BCR-ABL expressing BM cells. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.